Dual orexin receptor antagonist 12 inhibits expression of proteins in neurons and glia implicated in peripheral and central sensitization

Neuroscience

Volumn 269, Issue , 2014, Pages 79-92

  Cady, R J ^a   Denson, J E ^a   Sullivan, L Q ^a   Durham, P L ^a  

^a MISSOURI STATE UNIVERSITY   (United States)

Author keywords

Nociception; Orexin; Orexin receptor antagonist; Pain; Trigeminal nerve

Indexed keywords

ACTIN BINDING PROTEIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; AIF1 PROTEIN, RAT; AZEPINE DERIVATIVE; BENZIMIDAZOLE DERIVATIVE; CALCIUM BINDING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; DORA-12; FREUND ADJUVANT; HCRTR1 PROTEIN, RAT; HCRTR2 PROTEIN, RAT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OREXIN RECEPTOR;

ANIMAL; DRUG EFFECTS; GLIA; IMMUNOLOGY; MACROPHAGE; MALE; METABOLISM; NERVE CELL; NOCICEPTION; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TRIGEMINAL NUCLEUS; TRIGEMINUS GANGLION;

ANIMALS; AZEPINES; BENZIMIDAZOLES; CALCIUM-BINDING PROTEINS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FREUND'S ADJUVANT; MACROPHAGES; MALE; MICROFILAMENT PROTEINS; NEUROGLIA; NEURONS; NEUROTRANSMITTER AGENTS; NF-KAPPA B; NOCICEPTION; OREXIN RECEPTORS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRIGEMINAL GANGLION; TRIGEMINAL NUCLEUS, SPINAL;

EID: 84898645016     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.03.043     Document Type: Article

References (66)

1. Abbadie C., Bhangoo S., De Koninck Y., Malcangio M., Melik-Parsadaniantz S., White F.A. Chemokines and pain mechanisms. Brain Res Rev 2009, 60:125-134.
2. Al-Jundi M.A., John M.T., Setz J.M., Szentpetery A., Kuss O. Meta-analysis of treatment need for temporomandibular disorders in adult nonpatients. J Orofac Pain 2008, 22:97-107.
3. Bartsch T., Levy M.J., Knight Y.E., Goadsby P.J. Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area. Pain 2004, 109:367-378.
4. Benarroch E.E. Central neuron-glia interactions and neuropathic pain: overview of recent concepts and clinical implications. Neurology 2010, 75:273-278.
5. Bingham S., Davey P.T., Babbs A.J., Irving E.A., Sammons M.J., Wyles M., Jeffrey P., Cutler L., Riba I., Johns A., Porter R.A., Upton N., Hunter A.J., Parsons A.A. Orexin-A, an hypothalamic peptide with analgesic properties. Pain 2001, 92:81-90.
6. Cady R.J., Durham P.L. Cocoa-enriched diets enhance expression of phosphatases and decrease expression of inflammatory molecules in trigeminal ganglion neurons. Brain Res 2010, 1323:18-32.
7. Cady R.J., Glenn J.R., Smith K.M., Durham P.L. Calcitonin gene-related peptide promotes cellular changes in trigeminal neurons and glia implicated in peripheral and central sensitization. Mol Pain 2011, 7:94.
8. Cady R.J., Hirst J.J., Durham P.L. Dietary grape seed polyphenols repress neuron and glia activation in trigeminal ganglion and trigeminal nucleus caudalis. Mol Pain 2010, 6:91.
9. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999, 98:437-451.
10. Chiou L.C., Lee H.J., Ho Y.C., Chen S.P., Liao Y.Y., Ma C.H., Fan P.C., Fuh J.L., Wang S.J. Orexins/hypocretins: pain regulation and cellular actions. Curr Pharm Des 2010, 16:3089-3100.
11. Coleman P.J., Cox C.D., Roecker A.J. Discovery of dual orexin receptor antagonists (DORAs) for the treatment of insomnia. Curr Top Med Chem 2011, 11:696-725.
12. Coleman P.J., Renger J.J. Orexin receptor antagonists: a review of promising compounds patented since 2006. Expert Opin Ther Pat 2010, 20:307-324.
13. Cox C.D., Breslin M.J., Whitman D.B., Schreier J.D., McGaughey G.B., Bogusky M.J., Roecker A.J., Mercer S.P., Bednar R.A., Lemaire W., Bruno J.G., Reiss D.R., Harrell C.M., Murphy K.L., Garson S.L., Doran S.M., Prueksaritanont T., Anderson W.B., Tang C., Roller S., Cabalu T.D., Cui D., Hartman G.D., Young S.D., Koblan K.S., Winrow C.J., Renger J.J., Coleman P.J. Discovery of the dual orexin receptor antagonist [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the treatment of insomnia. J Med Chem 2010, 53:5320-5332.
14. Dai Y., Iwata K., Fukuoka T., Kondo E., Tokunaga A., Yamanaka H., Tachibana T., Liu Y., Noguchi K. Phosphorylation of extracellular signal-regulated kinase in primary afferent neurons by noxious stimuli and its involvement in peripheral sensitization. J Neurosci 2002, 22:7737-7745.
15. Davies A.J., Kim Y.H., Oh S.B. Painful neuron-microglia interactions in the trigeminal sensory system. Open Pain J 2010, 14-28.
16. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett F.S., Frankel W.N., van den Pol A.N., Bloom F.E., Gautvik K.M., Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 1998, 95:322-327.
17. DeLeo J.A., Tanga F.Y., Tawfik V.L. Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia. Neuroscientist 2004, 10:40-52.
18. Dublin P., Hanani M. Satellite glial cells in sensory ganglia: their possible contribution to inflammatory pain. Brain Behav Immun 2007, 21:592-598.
19. Dworkin S.F., LeResche L., DeRouen T., Von Korff M. Assessing clinical signs of temporomandibular disorders: reliability of clinical examiners. J Prosthet Dent 1990, 63:574-579.
20. Franceschini A., Vilotti S., Ferrari M.D., van den Maagdenberg A.M., Nistri A., Fabbretti E. TNFalpha levels and macrophages expression reflect an inflammatory potential of trigeminal ganglia in a mouse model of familial hemiplegic migraine. PLoS ONE 2013, 8:e52394.
21. Gao Y.J., Ji R.R. C-Fos and pERK, which is a better marker for neuronal activation and central sensitization after noxious stimulation and tissue injury?. Open Pain J 2009, 2:11-17.
22. Garrett F.G., Durham P.L. Differential expression of connexins in trigeminal ganglion neurons and satellite glial cells in response to chronic or acute joint inflammation. Neuron Glia Biol 2009, 1-12.
23. Garrett F.G., Hawkins J.L., Overmyer A.E., Hayden J.B., Durham P.L. Validation of a novel rat-holding device for studying heat- and mechanical-evoked trigeminal nocifensive behavioral responses. J Orofac Pain 2012, 26:337-344.
24. Gotter A.L., Webber A.L., Coleman P.J., Renger J.J., Winrow C.J. International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin receptor function, nomenclature and pharmacology. Pharmacol Rev 2012, 64:389-420.
25. Guo W., Wang H., Watanabe M., Shimizu K., Zou S., LaGraize S.C., Wei F., Dubner R., Ren K. Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci 2007, 27:6006-6018.
26. Herb K., Cho S., Stiles M. Temporomandibular joint pain and dysfunctioning. Curr Pain Headache Rep 2006, 10:408-414.
27. Holland P.R., Akerman S., Goadsby P.J. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception. J Pharmacol Exp Ther 2005, 315:1380-1385.
28. Holland P.R., Akerman S., Goadsby P.J. Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat. Eur J Neurosci 2006, 24:2825-2833.
29. Hucho T., Levine J.D. Signaling pathways in sensitization: toward a nociceptor cell biology. Neuron 2007, 55:365-376.
30. Ikeda H., Kiritoshi T., Murase K. Contribution of microglia and astrocytes to the central sensitization, inflammatory and neuropathic pain in the juvenile rat. Mol Pain 2012, 8:43.
31. Isong U., Gansky S.A., Plesh O. Temporomandibular joint and muscle disorder-type pain in U.S. adults: the National Health Interview Survey. J Orofac Pain 2008, 22:317-322.
32. Ji R.R. Peripheral and central mechanisms of inflammatory pain, with emphasis on MAP kinases. Curr Drug Targets Inflamm Allergy 2004, 3:299-303.
33. Ji R.R., Gereau R.W., Malcangio M., Strichartz G.R. MAP kinase and pain. Brain Res Rev 2009, 60:135-148.
34. Latremoliere A., Woolf C.J. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain 2009, 10:895-926.
35. Lazarov N.E. Comparative analysis of the chemical neuroanatomy of the mammalian trigeminal ganglion and mesencephalic trigeminal nucleus. Prog Neurobiol 2002, 66:19-59.
36. Lee M. Neurotransmitters and microglial-mediated neuroinflammation. Curr Protein Pept Sci 2013, 14:21-32.
37. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., Elmquist J.K. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 2001, 435:6-25.
38. Mieda M., Sakurai T. Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders. Rationale for development and current status. CNS Drugs 2013, 27:83-90.
39. Mihara Y., Dohi K., Yofu S., Nakamachi T., Ohtaki H., Shioda S., Aruga T. Expression and localization of the orexin-1 receptor (OX1R) after traumatic brain injury in mice. J Mol Neurosci 2011, 43:162-168.
40. Miller K.E., Hoffman E.M., Sutharshan M., Schechter R. Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms. Pharmacol Ther 2011, 130:283-309.
41. Miller R.J., Jung H., Bhangoo S.K., White F.A. Cytokine and chemokine regulation of sensory neuron function. Handb Exp Pharmacol 2009, 417-449.
42. Milligan E.D., Watkins L.R. Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 2009, 10:23-36.
43. Mostafeezur R.M., Zakir H.M., Yamada Y., Yamamura K., Iwata K., Sessle B.J., Kitagawa J. The effect of minocycline on the masticatory movements following the inferior alveolar nerve transection in freely moving rats. Mol Pain 2012, 8:27.
44. Nakagawa T., Kaneko S. Spinal astrocytes as therapeutic targets for pathological pain. J Pharmacol Sci 2010, 114:347-353.
45. Nakamura R., Nishimura T., Ochiai T., Nakada S., Nagatani M., Ogasawara H. Availability of a microglia and macrophage marker, iba-1, for differential diagnosis of spontaneous malignant reticuloses from astrocytomas in rats. J Toxicol Pathol 2013, 26:55-60.
46. Ozcan M., Ayar A., Serhatlioglu I., Alcin E., Sahin Z., Kelestimur H. Orexins activates protein kinase C-mediated Ca(2+) signaling in isolated rat primary sensory neurons. Physiol Res/Acad Sci Bohemoslov 2010, 59:255-262.
47. Pu S., Xu Y., Du D., Yang M., Zhang X., Wu J., Jiang W. Minocycline attenuates mechanical allodynia and expression of spinal NMDA receptor 1 subunit in rat neuropathic pain model. J Physiol Biochem 2013, 69:349-357.
48. Rainero I., De Martino P., Pinessi L. Hypocretins and primary headaches: neurobiology and clinical implications. Expert Rev Neurother 2008, 8:409-416.
49. Ren K. Neuron, glia and reciprocal relationships in pain processing. Open Pain J 2009, 2:7-31.
50. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
51. Sessle B.J. Peripheral and central mechanisms of orofacial pain and their clinical correlates. Minerva Anestesiol 2005, 71:117-136.
52. Sessle B.J. Peripheral and central mechanisms of orofacial inflammatory pain. Int Rev Neurobiol 2011, 97:179-206.
53. Seybold V.S. The role of peptides in central sensitization. Handb Exp Pharmacol 2009, 451-491.
54. Shinal R.M., Fillingim R.B. Overview of orofacial pain: epidemiology and gender differences in orofacial pain. Dent Clin North Am 2007, 51:1-18.
55. Sutcliffe J.G., de Lecea L. The hypocretins: excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. J Neurosci Res 2000, 62:161-168.
56. Suzuki I., Harada T., Asano M., Tsuboi Y., Kondo M., Gionhaku N., Kitagawa J., Kusama T., Iwata K. Phosphorylation of ERK in trigeminal spinal nucleus neurons following passive jaw movement in rats with chronic temporomandibular joint inflammation. J Orofac Pain 2007, 21:225-231.
57. Thompson W.L., Van Eldik L.J. Inflammatory cytokines stimulate the chemokines CCL2/MCP-1 and CCL7/MCP-3 through NFkB and MAPK dependent pathways in rat astrocytes [corrected]. Brain Res 2009, 1287:47-57.
58. Thut P.D., Hermanstyne T.O., Flake N.M., Gold M.S. An operant conditioning model to assess changes in feeding behavior associated with temporomandibular joint inflammation in the rat. J Orofac Pain 2007, 21:7-18.
59. Uceyler N., Schafers M., Sommer C. Mode of action of cytokines on nociceptive neurons. Exp Brain Res 2009, 196:67-78.
60. Urbanska A., Sokolowska P., Woldan-Tambor A., Bieganska K., Brix B., Johren O., Namiecinska M., Zawilska J.B. Orexins/hypocretins acting at Gi protein-coupled OX 2 receptors inhibit cyclic AMP synthesis in the primary neuronal cultures. J Mol Neurosci 2012, 46:10-17.
61. Villa G., Ceruti S., Zanardelli M., Magni G., Jasmin L., Ohara P.T., Abbracchio M.P. Temporomandibular joint inflammation activates glial and immune cells in both the trigeminal ganglia and in the spinal trigeminal nucleus. Mol Pain 2010, 6:89.
62. Winrow C.J., Renger J.J. Discovery and development of orexin receptor antagonists as therapeutics for insomnia. Br J Pharmacol 2013.
63. Woldan-Tambor A., Bieganska K., Wiktorowska-Owczarek A., Zawilska J.B. Activation of orexin/hypocretin type 1 receptors stimulates cAMP synthesis in primary cultures of rat astrocytes. Pharmacol Rep 2011, 63:717-723.
64. Xie Y.F. Glial involvement in trigeminal central sensitization. Acta Pharmacol Sin 2008, 29:641-645.
65. Xie Y.F., Zhang S., Chiang C.Y., Hu J.W., Dostrovsky J.O., Sessle B.J. Involvement of glia in central sensitization in trigeminal subnucleus caudalis (medullary dorsal horn). Brain Behav Immun 2007, 21:634-641.
66. Yan J.A., Ge L., Huang W., Song B., Chen X.W., Yu Z.P. Orexin affects dorsal root ganglion neurons: a mechanism for regulating the spinal nociceptive processing. Physiol Res/Acad Sci Bohemoslov 2008, 57:797-800.